Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients

Table 2

Weight loss of 446 patients in 3 and 6 months. (LOCF).

N = 446 238 F/208 M	Initial body weight (kg)	Final body weight (kg)	Weight loss (kg)	Weight loss (%)
Baseline	106.6	—	—	—
	95.1 F, 119.7 M
3 months	106.6	98.3	8.3	7.8%
	95.1 F, 119.7 M	87.9 F, 110.2 M	7.2 F, 9.5 M	7.6% F, 7.9% M
6 months	106.6	97.4	9.2	8.6%
	95.1 F, 119.7 M	86.9 F, 109.3 M	8.2 F, 10.4 M	8.6% F, 8.7% M

$N$ = number of individuals included in the study; F = female; M = male.